Skip to main content
Year archive

Elanix Biotechnologies AG — 2017 filings

All 41 regulatory filings released by Elanix Biotechnologies AG (ELN) in 2017, sourced directly from the official regulator.

41 Filings
2017 Period
2017 filings (41)
Filing Released Lang
Elanix's Partner Transwell Biotech Completes Phase I of Phase I/II Clinical Trial with Progenitor Cell Treatment for Skin Graft Wounds
Regulatory Filings
2017-12-27 English
Elanix Biotechnologies AG Announces Continuation of Private Placement at Subscription Price of EUR 4.20
Share Issue/Capital Change
2017-12-12 English
Elanix Biotechnologies Signs Agreement with Dermacon to Develop Progenitor Cell Medical Devices to Accelerate Wound Healing
M&A Activity
2017-12-01 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-11-23 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-11-23 English
Elanix Biotechnologies AG to Present at German Equity Forum 2017
Regulatory Filings
2017-11-23 English
Elanix Biotechnologies AG Announces Subscription Period and Subsequent Private Placement to Commence on November 23, 2017
Share Issue/Capital Change
2017-11-22 English
Elanix Biotechnologies AG: Announces Subscription Price for New Shares in Capital Increase
Capital/Financing Update
2017-11-10 English
Elanix Biotechnologies AG: Agreement in principle reached on the conditions for a non-cash capital increase against a contribution in kind for the progenitor bone cell bank from Inno 4 Cell AG
Capital/Financing Update
2017-10-17 English
Elanix Biotechnologies Announces First Half 2017 Financial Results
Earnings Release H1 2017
2017-09-29 English
Elanix Biotechnologies Subsidiary Signs Wholesale & Logistics Agreement in Europe to Support Expanding Commercialization of GYNrepair(R)
Regulatory Filings
2017-09-20 English
Elanix Biotechnologies AG: Annual General Meeting resolves cash capital increase with preemptive rights at a subscription ratio of 4:1
AGM Information
2017-08-24 English
ELANIX BIOTECHNOLOGIES AG STARTS DUE DILIGENCE TO ACQUIRE A FETAL PROGENITOR BONE CELL LINE WITHIN A CAPITAL INCREASSE BY WAY OF CONTRIBUTION IN KIND
Share Issue/Capital Change
2017-08-22 English
Elanix Biotechnologies AG: Elanix Biotechnologies's Partner Transwell Biotech Starts First Clinical Study with Progenitor Cell Treatment for Skin Graft Wounds
Regulatory Filings
2017-07-20 English
Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2017-07-18 German
Elanix Biotechnologies AG: Vorstand und Aufsichtsrat schlagen der ordentlichen Hauptversammlung 2017 eine Bar-Kapitalerhohung um bis zu 50% mit mittelbarem Bezugsrecht vor
Capital/Financing Update
2017-07-13 German
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-07-03 English
Elanix Biotechnologies AG: Torsten Cejka, Chairman of the Supervisory Board resigns effective on the date of next General Meeting
Board/Management Information
2017-06-29 English
Report Publication Announcement 2017
Report Publication Announcement
2017-06-28 English
Elanix Biotechnologies Launches Adherence App for GYNrepair(R) Women's Intimate Health Cream
Regulatory Filings
2017-06-27 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-06-21 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-06-20 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-06-19 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-06-19 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-06-19 English
Report Publication Announcement 2017
Report Publication Announcement
2017-04-26 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-04-24 English
Elanix Biotechnologies AG: Restatement gem. IAS 8 im Rahmen des Konzernabschlusses 2016 geplant/Vorlaufige, ungeprufte Konzernzahlen zum Geschaftsjahr 2016 und Ausblick
Earnings Release FY 2016
2017-04-15 German
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-03-22 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-03-17 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-03-15 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-03-10 English
DGAP-DD: Elanix Biotechnologies AG english
Director's Dealing
2017-03-10 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-03-10 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2017-03-09 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-03-07 English
Elanix Biotechnologies AG: capital increase successfully placed, gross issuing proceeds amount to some EUR 4.76 million
Capital/Financing Update
2017-02-24 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-02-16 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-01-31 English
Elanix Biotechnologies AG initiates a cash capital increase from authorized capital of up to 1,133,200 new shares with indirect shareholder subscription rights
Capital/Financing Update
2017-01-30 English
Elanix Biotechnologies AG: CEO informs about planned cash capital increase with indirect subscription rights
Share Issue/Capital Change
2017-01-13 English